Dysregulation of Receptor for Advanced Glycation End Products (RAGE) Expression as a Biomarker of Keratoconus
暂无分享,去创建一个
F. Dutheil | F. Malecaze | V. Sapin | L. Blanchon | C. Belville | V. Navel | J. Malecaze | Helena Choltus | Fanny Henrioux | F. Chiambaretta | Hélèna Choltus
[1] M. Borgstrom,et al. Keratoconus: Diagnosis and Staging. , 2021, Cornea.
[2] J. Baker,et al. Oxidative and antioxidative stress markers in keratoconus: a systematic review and meta‐analysis , 2020, Acta ophthalmologica.
[3] V. Sapin,et al. Advanced Glycation End Products and Receptor (RAGE) Promote Wound Healing of Human Corneal Epithelial Cells , 2020, Investigative ophthalmology & visual science.
[4] M. Saatchi,et al. The Prevalence and Risk Factors for Keratoconus: A Systematic Review and Meta-Analysis. , 2019, Cornea.
[5] A. Jinabhai. Customised aberration‐controlling corrections for keratoconic patients using contact lenses , 2020, Clinical & experimental optometry.
[6] V. Pialoux,et al. Receptor for Advanced Glycation End Products Antagonism Blunts Kidney Damage in Transgenic Townes Sickle Mice , 2019, Front. Physiol..
[7] J. Rozema,et al. Keratoconus Natural Progression: A Systematic Review and Meta-analysis of 11 529 Eyes. , 2019, Ophthalmology.
[8] C. Inglehearn,et al. Matrix metalloproteinases in keratoconus – Too much of a good thing? , 2019, Experimental eye research.
[9] K. Tracey,et al. Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation , 2019, Molecular medicine.
[10] N. T. ten Hacken,et al. AGER expression and alternative splicing in bronchial biopsies of smokers and never smokers , 2019, Respiratory Research.
[11] V. Sapin,et al. Inhibition of the Receptor for Advanced Glycation End-Products in Acute Respiratory Distress Syndrome: A Randomised Laboratory Trial in Piglets , 2018, bioRxiv.
[12] M. Zetterberg,et al. Toric IOL implantation in a patient with keratoconus and previous penetrating keratoplasty: a case report and review of literature , 2018, BMC Ophthalmology.
[13] J. Xu,et al. Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy , 2018, Cellular Physiology and Biochemistry.
[14] G. Van Camp,et al. A new perspective on the genetics of keratoconus: why have we not been more successful? , 2018, Ophthalmic genetics.
[15] J. Y. Kim,et al. Production and application of HMGB1 derived recombinant RAGE‐antagonist peptide for anti‐inflammatory therapy in acute lung injury , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[16] V. Deltuva,et al. The Association Between Variants of Receptor for Advanced Glycation End Products (RAGE) Gene Polymorphisms and Age-Related Macular Degeneration , 2018, Medical science monitor : international medical journal of experimental and clinical research.
[17] Bin Wang,et al. Efficacy and safety of transepithelial corneal collagen crosslinking surgery versus standard corneal collagen crosslinking surgery for keratoconus: a meta-analysis of randomized controlled trials , 2017, BMC Ophthalmology.
[18] Yan Mei,et al. Association between the RAGE (receptor for advanced glycation end-products) -374T/A gene polymorphism and diabetic retinopathy in T2DM. , 2017, Revista da Associacao Medica Brasileira.
[19] S. Rehman,et al. Oxidation, glycation and glycoxidation-The vicious cycle and lung cancer. , 2017, Seminars in cancer biology.
[20] Yi‐Jen Chen,et al. ADAM10 modulates calcitriol‐regulated RAGE in cardiomyocytes , 2017, European journal of clinical investigation.
[21] V. Sapin,et al. RAGE inhibition reduces acute lung injury in mice , 2017, Scientific Reports.
[22] S. Rehman,et al. AGEs, RAGEs and s-RAGE; friend or foe for cancer. , 2017, Seminars in cancer biology.
[23] A. Jun,et al. Changing Indications in Penetrating Keratoplasty: A Systematic Review of 34 Years of Global Reporting , 2017, Transplantation.
[24] M. Gazouli,et al. Receptor of Advanced Glycation End Products Gene Polymorphism and Primary Open-Angle Glaucoma , 2017, Ophthalmic Research.
[25] P. Reynolds,et al. Inhibition of the receptor for advanced glycation end-products (RAGE) protects from secondhand smoke (SHS)-induced intrauterine growth restriction IUGR in mice , 2017, Cell and Tissue Research.
[26] C. Uiterwaal,et al. Age-specific Incidence and Prevalence of Keratoconus: A Nationwide Registration Study. , 2017, American journal of ophthalmology.
[27] Mutsa P. Seremwe,et al. Molecular and Histopathological Changes Associated with Keratoconus , 2017, BioMed research international.
[28] R. Shetty,et al. Tear biomarkers for keratoconus , 2016, Eye and Vision.
[29] R. Nagaraj,et al. AGE-RAGE interaction in the TGFβ2-mediated epithelial to mesenchymal transition of human lens epithelial cells , 2016, Glycoconjugate Journal.
[30] T. Radstake,et al. Cytokine Expression in Keratoconus and its Corneal Microenvironment: A Systematic Review. , 2015, The ocular surface.
[31] S. Tabrez,et al. Lycopene powers the inhibition of glycation-induced diabetic nephropathy: a novel approach to halt the AGE-RAGE axis menace. , 2015, BioFactors.
[32] K. van Dijk,et al. Treatment options for advanced keratoconus: A review. , 2015, Survey of ophthalmology.
[33] T. Sherwin,et al. Keratoconus: an inflammatory disorder? , 2015, Eye.
[34] E. Duh,et al. Induction of endothelial RAGE expression in pterygium , 2014, Molecular vision.
[35] Jianling Xie,et al. Cellular signalling of the receptor for advanced glycation end products (RAGE). , 2013, Cellular signalling.
[36] Sundaram Natarajan,et al. Keratoconus , 2013, Indian journal of ophthalmology.
[37] T. Corydon,et al. Update on the keratoconus genetics , 2013, Acta ophthalmologica.
[38] M. Hauser,et al. The Genetics of Keratoconus: A Review. , 2012, Reproductive system & sexual disorders : current research.
[39] P. Hessian,et al. The G82S Polymorphism Promotes Glycosylation of the Receptor for Advanced Glycation End Products (RAGE) at Asparagine 81 , 2011, The Journal of Biological Chemistry.
[40] F. Santilli,et al. Soluble forms of RAGE in internal medicine , 2009, Internal and emergency medicine.
[41] T. Sobrino,et al. Subclinical keratoconus and inflammatory molecules from tears , 2009, British Journal of Ophthalmology.
[42] E. Kojro,et al. Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases* , 2008, Journal of Biological Chemistry.
[43] W. Green,et al. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty. , 2007, Ophthalmology.
[44] C. McGhee,et al. The variable expression of keratoconus within monozygotic twins: dundee University Scottish Keratoconus Study (DUSKS). , 2006, Contact lens & anterior eye : the journal of the British Contact Lens Association.
[45] K. Schechtman,et al. Longitudinal Changes in Corneal Curvature in Keratoconus , 2006, Cornea.
[46] D. Stern,et al. Understanding RAGE, the receptor for advanced glycation end products , 2005, Journal of Molecular Medicine.
[47] R. D. Stulting,et al. Asymmetric Keratoconus Attributed to Eye Rubbing , 2004, Cornea.
[48] Y. Rabinowitz. The genetics of keratoconus. , 2003, Ophthalmology clinics of North America.
[49] N. Sarvananthan,et al. Does ethnic origin influence the incidence or severity of keratoconus? , 2000, Eye.
[50] W. Hodge,et al. Atopy and keratoconus: a multivariate analysis , 2000, The British journal of ophthalmology.
[51] D. Gatinel. Eye rubbing , a sine Qua Non for Keratoconus ? , 2016 .
[52] Y. Pouliquen,et al. [Keratoconus and inflammatory processes]. , 1996, Bulletin de la Societe belge d'ophtalmologie.
[53] J. Krachmer,et al. Keratoconus and related noninflammatory corneal thinning disorders. , 1984, Survey of ophthalmology.
[54] D. Sabiston. The association of keratoconus, dermatitis and asthma. , 1966, Transactions of the Ophthalmological Society of New Zealand.
[55] C. Teng. Electron Microscope Study of The Pathology of Keratoconus: Part I* , 1963 .